Calamos Advisors LLC Acquires New Shares in Tempus AI, Inc. (NASDAQ:TEM)

Calamos Advisors LLC acquired a new stake in Tempus AI, Inc. (NASDAQ:TEM - Free Report) during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 6,782 shares of the company's stock, valued at approximately $327,000.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Cherry Tree Wealth Management LLC bought a new position in shares of Tempus AI during the 1st quarter valued at $31,000. Operose Advisors LLC purchased a new stake in shares of Tempus AI in the 4th quarter worth $25,000. Bartlett & CO. Wealth Management LLC increased its stake in shares of Tempus AI by 100.0% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 800 shares of the company's stock worth $39,000 after purchasing an additional 400 shares in the last quarter. Continuum Advisory LLC purchased a new stake in shares of Tempus AI in the 1st quarter worth $39,000. Finally, Farther Finance Advisors LLC purchased a new stake in shares of Tempus AI in the 4th quarter worth $34,000. 24.22% of the stock is owned by institutional investors.

Tempus AI Trading Down 4.9%

Shares of Tempus AI stock opened at $58.01 on Tuesday. The firm has a market cap of $10.04 billion and a price-to-earnings ratio of -7.44. The business has a 50-day moving average price of $62.61 and a 200-day moving average price of $54.42. The company has a quick ratio of 1.56, a current ratio of 1.71 and a debt-to-equity ratio of 2.45. Tempus AI, Inc. has a twelve month low of $30.81 and a twelve month high of $91.45.

Tempus AI (NASDAQ:TEM - Get Free Report) last issued its quarterly earnings data on Tuesday, May 6th. The company reported ($0.24) earnings per share for the quarter, beating analysts' consensus estimates of ($0.27) by $0.03. The firm had revenue of $255.74 million during the quarter, compared to analyst estimates of $248.13 million. Tempus AI had a negative return on equity of 533.21% and a negative net margin of 88.27%. The business's revenue was up 75.4% on a year-over-year basis. Equities research analysts anticipate that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.

Insider Activity

In related news, EVP Erik Phelps sold 51,317 shares of the stock in a transaction dated Monday, June 16th. The shares were sold at an average price of $72.56, for a total value of $3,723,561.52. Following the completion of the transaction, the executive vice president owned 97,779 shares of the company's stock, valued at approximately $7,094,844.24. This trade represents a 34.42% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO James William Rogers sold 23,121 shares of the stock in a transaction dated Tuesday, May 20th. The shares were sold at an average price of $63.27, for a total transaction of $1,462,865.67. Following the completion of the transaction, the chief financial officer directly owned 146,001 shares of the company's stock, valued at approximately $9,237,483.27. The trade was a 13.67% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 607,522 shares of company stock valued at $41,300,238. 27.60% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on TEM. Guggenheim upped their price objective on Tempus AI from $65.00 to $75.00 and gave the stock a "buy" rating in a research note on Monday, June 30th. Needham & Company LLC restated a "buy" rating and issued a $70.00 price objective on shares of Tempus AI in a research note on Wednesday, May 7th. BTIG Research initiated coverage on Tempus AI in a research note on Monday, April 21st. They issued a "buy" rating and a $60.00 price objective for the company. Piper Sandler increased their price target on Tempus AI from $55.00 to $70.00 and gave the stock a "neutral" rating in a research note on Thursday, May 15th. Finally, Morgan Stanley increased their price target on Tempus AI from $60.00 to $65.00 and gave the stock an "overweight" rating in a research note on Friday, May 9th. Six analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $63.67.

Tempus AI Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.